Yiwei Biotech key facts
- Developer of bio and pharmaceutical technology products based in Suzhou, Jiangsu.
- Notable investors include Leader Venture Capital, Tsingzhi Capital, Shanghai TusPark, CR Life Sciences, Hatchip Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·Watch Yiwei Biotech: the Monday email on marks, rounds and moves
Yiwei Biotech funding rounds
No funding rounds for Yiwei Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Yiwei Biotech investors
10 investors are on record for Yiwei Biotech, including Leader Venture Capital, Tsingzhi Capital, Shanghai TusPark and CR Life Sciences.
About Yiwei Biotech
Developer of bio and pharmaceutical technology products based in Suzhou, Jiangsu. The company's main business covers technology development, technical consultation, technical service, and technology transfer in the fields of biology and medical technology (except human stem cells, gene diagnosis and treatment technology development and application) and medical device management.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2019
- Employees
- 4
- Website
- carrierbiomed.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Yiwei Biotech doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.